Bone marrow stromal cells (BMSC) normally give rise to bone, cartilage, and mesenchymal cells. Recently, bone marrow cells have been shown to have the capacity to differentiate into myocytes, hepatocytes, and glial cells. We now demonstrate that human and mouse BMSC can be induced to differentiate into neural cells under experimental cell culture conditions. BMSC cultured in the presence of EGF or BDNF expressed the protein and mRNA for nestin, a marker of neural precursors. These cultures also expressed glial fibrillary acidic protein (GFAP) and neuron-specific nuclear protein (NeuN). When labeled human or mouse BMSC were cultured with rat fetal mesencephalic or striatal cells, a small proportion of BMSCderived cells differentiated into neuron-like cells expressing NeuN and glial cells expressing GFAP.
INTRODUCTION
The ancient Chinese believed bone marrow was the source of brain tissue as suggested by the maxim "brain is a sea of marrow" (17) . The existence of stem cells for nonhematopoietic cells in bone marrow was proposed over 100 years ago, but the isolation and differentiation of marrow stromal cells into osteoblasts, chondroblasts, adipocytes, and myoblasts was only recently demonstrated (see review (21) ). Nonhematopoietic precursors from bone marrow stroma have been referred to as colony-forming-unit fibroblasts, mesenchymal stem cells, or bone marrow stromal cells (BMSC). Although BMSC can naturally be expected to be a source of surrounding tissue of bone, cartilage, and fat, several recent reports demonstrate that these cells, under specific experimental conditions, can differentiate into muscle, glia, and hepatocytes (1, 8, 20) . Bone marrow cells also have the capacity to migrate extensively. Transplantation of genetically labeled bone marrow cells into immunodeficient mice has been reported to result in migration of marrow cells into a region of chemically induced muscle degeneration (8) . These marrow-derived cells underwent myogenic differentiation and participated in the regeneration of the damaged muscle fibers. Systemic infusion of genetically labeled bone marrow cells into irradiated female mice resulted in an influx of labeled cells into the brain over days to weeks (6) . Marrow-derived cells were found throughout regions of the brain, from cortex to brain stem. Some bone marrow-derived cells were positive for the microglial antigenic marker F4/80. Other marrow-derived cells expressed the astroglial marker glial fibrillary acidic protein (GFAP) (6) . These results indicated that some microglia and astroglia arose from a precursor that is a normal constituent of adult bone marrow. Other researchers have reported that infusion of human BMSC into rat striatum resulted in engrafting, migration, and survival of cells (1) . After engraftment, these cells lost markers typical of marrow stromal cells in culture, such as immunoreactivity to antibodies against collagen and fibronectin. BMSC developed many of the characteristics of astrocytes, and their engraftment and migration markedly contrasted with fibroblasts that continued to produce collagen and undergo gliosis after implantation. Grafting of BMSC into the lateral ventricle of neonatal mice resulted in their migration throughout the forebrain and cerebellum without disruption of host brain architecture (13) . Some BMSC in striatum and hippocampus were reported to express GFAP. Moreover, occasional neurofilament-positive BMSC were found in the brain stem suggesting that some BMSC differentiated into a neuronal phenotype (13) . All of these reports provide impetus to investigate the potential of bone marrow cells to develop into nonhematopoietic cells and, in particular, to generate neural lineages. To test the hypothesis that neural precursor cells can be derived from bone marrow cells, stromal cells from the marrow were induced to proliferate and then cultured under conditions that induce neuronal differentiation of embryonic or neural stem cells in vitro (5, 24) .
Preparation of Mouse Bone Marrow Cells
Mouse bone marrow cells were collected, after sacrifice of 8-week-old mice, from femurs and tibias by flushing the shaft with buffer (phosphate-buffered saline supplemented with 0.5% bovine serum albumin, pH 7.2) using a syringe with a No. 26 G needle. Cells were disaggregated by gentle pipetting several times. Cells were passed through 30-m nylon mesh to remove remaining clumps of tissue. Cells were washed by adding buffer, centrifuging for 10 min at 200g and removing supernatant. The cell pellet was resuspended in 800 l of buffer for each 10 8 cells.
Separation of Mouse Bone Marrow Hematopoietic Stem Cell Antigen (Sca1ϩ) Cells
Using a magnetic cell sorting kit (Milteny Biotec, Inc., Auburn, TX), bone marrow cells were labeled with Sca1ϩ or CD34ϩ microbeads, which label bone marrow cells that express stem cell antigen (Sca1 in mouse and CD34 in human). The labeled bone marrow cells were passed through an MSϩ column for positive selection of Sca1ϩ or CD34ϩ cells. Two hundred microliters of Sca1 Multi-sort MicroBeads was added per 10 8 total cells, mixed, and incubated for 15 min at 6 -12°C. Cells were washed by adding 5-10X the labeling volume of buffer, centrifuging for 10 min at 200g, and removing supernatant. The cell pellet was resuspended in 500 l buffer. The MSϩ/RSϩ column was washed with 500 l of buffer. The cell suspension was applied to the column and the negative cells were passed through. The column was then rinsed with 500 l of buffer three times. The column was removed from the separator (which contains the magnet) and placed on a suitable collection tube. One milliliter of buffer was pipetted onto the column and the positive fraction was flushed out with the plunger provided with the column.
Separation of BMSC from Human Bone Marrow Aspirates
Human bone marrow stromal cells were harvested from residual material (bone chips with adherent stromal cells, fatty tissue, and debris) retained on the nylon filters routinely used to clean freshly procured human marrow aspirates. The filtrate, which was not used in the present studies, was destined for bone marrow replacement therapies and contains the bulk of bone marrow cells, including the hematopoietic precursor cells. The nylon filter contained material that is usually discarded but was utilized as the starting material for generation of neural cells. This filter was back washed five times with normal sterile saline and centrifuged to remove bone chips. The bone marrow material was diluted 1:1 with Dulbecco's minimal essential media (DMEM, GIBCO/BRL) and 10% fetal bovine serum (FBS) and centrifuged through a density gradient (Ficoll-Paque Plus, 1.077 g/ml, Pharmacia) for 30 min at 1000 g. The supernatant and interface were combined and diluted to approximately 20 ml with growth medium and plated in polyethylene-iminecoated plastic flasks. The growth medium consisted of DMEM supplemented with 2 mM glutamine, 0.001% ␤-mercaptoethanol, nonessential amino acids, 10% horse serum, and either human leukemia inhibitory factor (hLIF) or epidermal growth factor (EGF), 10 ng/ml. The cells were incubated at 37°C in 5% CO 2 in flasks for 2 days and nonadherent cells were removed by replacing the medium. After the cultures reached confluency, usually within a week, the cells were lifted by incubation with trypsin (0.25%) and 1 mM EDTA at 37°C for 3-4 min. They were then frozen for later use or replated after 1:2 or 1:3 dilution with the addition of EGF (10 ng/ml). Cells used in these experiments were harvested from the first or second passage.
Preparation of Rat or Mouse Fetal Midbrain Cell Suspensions for Coculturing with BMSC Cells
Fetal midbrain cell suspensions were prepared from ventral midbrain from rat or mouse embryos at 14 days of gestation dissected in HBSS (Hanks' balanced salt solution; GIBCO BRL, Life Technologies, Gaithersburg, MD) ϩ15 mM Hepes (GIBCO BRL) as previously described (15, 23) . After 3 days in vitro, BMSC were added to the midbrain culture layer in an approximately 1:1 ratio of cells.
Differentiation Procedure
Cells removed from the flask bottom after the first or second passage as above (BMSC) were replated in 35-mm culture dishes in the presence of a neuronal growth medium (N5) (11) supplemented with 5% horse serum, 1% FBS, transferrin (100 g/ml), putrescine (60 M), insulin (25 g/ml), progesterone (0.02 M), selenium (0.03 M), all-trans-retinoic acid (0.5 M), and BDNF at a concentration of 10 ng/ml. After 7 to 14 days, BMSC were processed for immunocytochemistry, Western blotting, or rt-PCR.
Immunocytofluorescence and Immunocytochemistry
Bone marrow stromal cells were visualized following fixation (4% buffered paraformaldehyde) and processing for immunocytochemistry with antibodies to fibronectin (rabbit polyclonal, Sigma, Inc.) (1:400) followed by biotinylated anti-rabbit antibody and an avidin-biotin conjugate of horseradish peroxidase (Vectorstain, Vector Laboratory Burlingame, CA). Visualization of neural cells (neurons and glia) utilized immunocytofluorescence technique and confocal fluorescence microscopy. In the coculture experiments, human BMSC were prelabeled with 20 M concentration of fluorescent green "cell tracker" (5-chloromethyl fluo- recein diacetate, Molecular Probes, Inc.) or red fluorescent PKH-26 (Sigma, Inc.) and plated in 35-mm polyethyleneimine-coated culture dishes. After 2 or 3 days, BMSC cells were added to the rat midbrain cells. After 1-2 weeks in culture, cells were processed for immunocytofluorescence using primary antibodies against NeuN (mouse monoclonal, Chemicon, Inc.) (1:100), GFAP (rabbit polyclonal, Biogenex, Inc.) (1:100), nestin (mouse monoclonal, Chemicon, Inc.) (1:250), and MAP2 (mouse monoclonal, Chemicon, Inc.) (1:200), followed by Texas red or fluorescein-labeled secondary antibody.
A Zeiss laser scanning confocal microscope (Model LSM 510) use used to visualize fluorescence in two separate channels. For work with BMSC obtained from transgenic lacZ mouse (Jackson Labs), ␤-gal staining was performed using a kit for light-microscopic visualization of the blue reaction product catalyzed by ␤-galactosidase (Invitrogen, Inc.).
Estimates of Cell Number
Estimates of positively stained cells were based on counting cells in 20 random visual fields (20X objective) in four culture dishes for each marker in a minimum of three different experiments. When positively stained cells were present in every field (e.g., fibronectin-ir cells), the mean and SEM of cells per field were calculated and compared with cell counts prepared under different conditions using a two-tailed t test. When cells stained with antibodies to nestin, GFAP, or NeuN, their presence was rare and estimates of the number of positive cells was made by counting the average number of visual fields viewed before finding a positive cell. A cell that was found on the average after viewing 20 visual fields (each field of which contains an average of 8 total cells) corresponds to approximately 1/160 cells or 0.65% of the total number of cells and 1 per 30 fields corresponds to 0.4% of total cells.
Western Blotting
Cultures were washed three times in cold phosphatebuffered saline (PBS), scraped into ice-cold PBS, and lysed in an ice-cold lysis buffer containing 20 nM TrisHCl (pH 8.0), 0.2 mM EDTA, 3% Nonidet P-40, 2 mM orthovanadate, 50 mM NaF, 10 mM sodium pyrophosphate, 100 mM NaCl, and 10 g each of aprotinin and leupeptin per milliliter. After incubation on ice for 10 min, the samples were centrifuged at 14,000g for 15 min and the supernatants were collected. An aliquot was removed for total protein estimation (Bio-Rad assay). An aliquot corresponding to 10 g of total protein of each sample was separated by SDS-PAGE (10%) under reducing conditions and transferred electrophoretically to nitrocellulose filters. Nonspecific binding of antibody was blocked with 5% nonfat dry milk overnight at 4°C. Immunoblotting was carried out with rabbit polyclonal antibody to GFAP (Biogenex, Inc.) or mouse monoclonal antibody to nestin or neuron-specific nuclear protein (NeuN) (both purchased from Chemicon, Inc.) followed by peroxidase-conjugated secondary anti-immunoglobulin antibodies, and the blots were developed by the enhanced chemiluminescence method (ECL, Amersham).
Reverse Transcriptase Polymerase Chain Reaction (rt-PCR)
Total RNA from cells and tissues was isolated by the guanidine isothiocyanate method (3) and total RNA (2-5 g) was reverse transcribed using the Superscript kit (GIBCO/BRL). The upstream sense primer for detection of human nestin was 5Ј CAGGCTTCTCTTG-GCTTTCTGG 3Ј and the downstream antisense primer was 5Ј TGGTGAGGGTTGAGGTTTGT 3Ј. Probes were labeled with [ 32 P]dCTP using a random primer labeling system (Promega). After hybridization, membranes were washed as described (9) . Following 30 cycles of amplification (94°C, 1 min; 56°C, 1 min; and 72°C, 1 min) in a Hybaid thermoblock, 25% of the PCR reaction was resolved on a 1.2% agarose gel. A 360-bp band was observed under UV light and photographed. Each analysis was repeated three times with similar results.
RESULTS
Treatment of BMSC cultures with hLIF failed to induce proliferation of mouse and human cells, regardless of whether they were enriched or depleted of hematopoietic stem cells. Instead, incubation of BMSC with hLIF resulted in differentiation into cells with fibroblastic morphologies. This is very unlike the effects of hLIF on mouse embryonic stem cells in which this factor has been shown to be essential for keeping embryonic stem cells in a proliferating, undifferentiated state (4, 25) . The remainder of experiments described below utilized EGF (10 ng/ml) as the mitogen to induce proliferation of the plated BMSC. Other researchers have reported that the LIF family of cytokines does not promote proliferation of neural precursor cells in an undifferentiated state, similar to our observations of their effect on marrow cells (12) . Instead, they have been implicated in the regulation of astrocyte differentiation from neural precursors of the developing forebrain (12) .
Differentiation of BMSC into Neuron-like and Glial-like Cells
Incubation of BMSC with "differentiation medium" that contained 10% fetal calf serum (FCS), 0.5 M all-trans-retinoic acid (RA), and BDNF (10 ng/ml) resulted in a significant decrease in the proportion of fibronectin-ir cells in the cultures (see Fig. 1 ). There was a trend for the total number of cells in the cultures to decrease but this did not reach statistical significance. The decrease in numbers of fibronectin-ir cells was primarily due to loss of expression of fibronectin and a concomitant change in cell morphologies ( Figs.  2A and 2B) . The large flat fibronectin-containing BMSC were transformed into spindle-shaped fibroblastic appearing cells with long processes. Many smaller oval cells with short processes did not show fibronectin immunoreactivity. Immunocytofluorescence analysis of these cultures revealed the occasional presence of nestin-ir, NeuN-ir, and GFAP-ir cells, which were much smaller in size than the fibronectin-ir cells (Fig.  3) . These cells were oval or spindle-shaped with short processes and were present in very much smaller proportion than the predominant fibronectin-ir stromal cells. NeuN-ir and GFAP-ir cells numbered 0.5 and 1%, respectively, of the total number of fibronectin-ir cells. Western blots of cell culture lysates of these cultures demonstrated the presence of the proteins nestin, NeuN, and GFAP in human BMSC (Fig. 4) . The expression of nestin protein relative to ␣-tubulin was decreased in cultures treated with RA or RA ϩ BDNF. These results were consistent across three separate experiments. Interestingly, both GFAP and NeuN were expressed by BMSC under culture all conditions, including growth in the presence of N5 medium alone. Nestin mRNA was also detected by rt-PCR (19) in RNA prepared from human BMSC cultured in the presence of EGF (10 ng/ml) or retinoic acid (0.5 M) and BDNF (10 ng/ml) (Fig. 5) . Although there appears to be differing intensities of signal on the blots, this method can not be used to quantify mRNA.
Cocultures of BMSC (Labeled with ␤-Gal or Fluorescent Markers) and Fetal Rat Midbrain Cells
To determine whether cellular environment would augment neuronal differentiation of BMSC-derived cells, we studied the effects of coculturing BMSC with fetal primary neuronal cultures. The BMSC were identified by using ␤-galactosidase-expressing bone marrow cells prepared from transgenic lacZ mice. In a second set of experiments, the BMSC were labeled with either green fluorescent "cell tracker" or the red fluorescent PKH-26. The lacZ BMSC were plated (2.5 ϫ 10 5 cells/dish) on fetal mouse mesencephalic cell cultures (2.5 ϫ 10 5 cells per dish) prepared as previously described (23) . Retinoic acid (0.5 M) and BDNF (10 ng/ml) were added to the N5 medium. After 2 weeks, cultures were fixed and processed for histochemical and immunocytochemical staining. ␤-Galactosidasepositive cells were clearly identified by blue staining visualized under bright field microscopy (See Fig. 6 ).
Neurons were identified by NeuN immunoreactivity. Approximately 2-5% of ␤-galactosidase-positive cells were also positive for NeuN, a much greater proportion of neuron-like cells than observed when BMSC were cultured alone. A very small proportion (Ͻ0.1%) of control fetal midbrain cultures also stained positive for ␤-gal, reflecting the endogenous expression of ␤-galactosidase activity (10) . The increase in the number of NeuN-ir BMSC in the presence of fetal neuronal cultures was significantly greater (at least twofold) than when BMSC were cultured alone or when compared to numbers of ␤-galϩ cells seen in control fetal midbrain cultures.
An alternative marker was also utilized to label the BMSC. Human BMSC were labeled with 20 M red fluorescent PKH-26 (Sigma, Inc.) or fluorescent green "cell tracker" (5 chloromethyl fluorecein diacetate, Molecular Probes, Inc.) and plated on a cell bed of rat midbrain cells prepared 3 days earlier.
Cultures were fed with all-trans-RA (0.5 M) ϩ BDNF (10 ng/ml) in N5 medium. After 1 week in culture, cells were processed for immunocytofluorescence using primary antibodies against NeuN, GFAP, nestin, and MAP2, followed by Texas red or fluorescein-labeled secondary antibody. This permitted a dual labeling of cells to determine whether the cells that exhibited specific markers for neurons, glia, or nestin had a bone marrow origin (see Fig. 7 ). In cultures stained for NeuN immunoreactivity, 2 to 4% of the BMSC-derived cells in culture were doublelabeled and had the phenotype of immature neuronlike cells (Figs. 7A-7I ). The cells were ovoid or spindle-shaped with bipolar processes. Labeled BMSC were found adjacent to well-developed MAP2-ir neurons of fetal midbrain origin (Figs. 7J-7L ), but no BMSC-derived cells were found that reliably expressed MAP2 in a clearly neuronal phenotype. BMSC raised alone in the absence of fetal cell cultures were also found to not express MAP2. In cultures stained for GFAP immunoreactivity 5 to 8% of the BMSC-derived cells were double-labeled (Fig. 8) .
The majority of the double-labeled GFAP-ir cells had an ovoid or spindle-shaped morphology with short processes similar to those of the NeuN-ir cells (Fig.  8I ), but some GFAP-ir BMSC were irregular in shape (Fig. 8F ) and approximated the morphology of glial cells. GFAP-ir cells at least twofold. These results were confirmed in a second set of experiments that utilized BMSC labeled with two different fluorescent vital stains. The coculture experiments support the hypothesis that cell to cell contact, in addition to signaling with trophic factors and cytokines, plays an important role in differentiation of these BMSC. The neural cells produced from BMSC in the cocultures did not exhibit the morphology of mature neurons or glia, nor did they express MAP2, a marker of mature neurons. This may be due to the short duration of incubation (maximum of 2 weeks) and a slower maturation rate for humanderived cells. Other markers of neuronal development, such as neurofilaments or ␤-III-tubulin (7), were not tested in this series of experiments. The expression of NeuN, but not MAP2 in BMSC-derived cells, is consistent with current knowledge regarding the timepoints of expression of neuronal proteins. MAP2 is expressed at a later developmental stage than NeuN. Immunohistochemically detectable NeuN protein has been reported to first appear at developmental timepoints that correspond with the withdrawal of the neuron from the cell cycle and/or with the initiation of terminal differentiation of the neuron (18) . In contrast, the microtubule-associated proteins (MAP1, -2, and -3) undergo a number of significant changes during development, with the expression of MAP2 considered to occur "late," particularly between 10 and 20 days in the postnatal rat pup (22) .
These results, along with those published by others, suggest that adult BMSC have a potentially larger developmental repertoire than previously appreciated. It should not be surprising that BMSC can give rise to neural cells since the marker for neural precursors, nestin, was expressed in BMSC even in the absence of the differentiation factors retinoic acid and BDNF. Moreover, BMSC have been shown to have the capacity to develop into hepatocytes, muscle, glia, and neuron-like cells under experimental conditions (1, 5, 15, 19) . Interestingly, these cells have the capacity to migrate extensively and to exhibit a site-dependent differentiation. For example, the infusion via tail vein of retrovirus-labeled male bone marrow cells into irradiated female mice resulted in the influx of hematopoietic cells into brain over days to weeks (6) . The marrow-derived cells were found in cerebral cortex, hippocampus, thalamus, brain stem, and cerebellum. Some marrow-derived cells expressed the microglial antigenic marker and others expressed the astroglial marker GFAP (6) . BMSC injected into the lateral ventricles of newborn mice migrated extensively and differentiated into glial cells and occasionally into cells that expressed neurofilament (13) . Differentiation in the opposite direction has also been recently reported. Adult neural stem cells transplanted into irradiated hosts developed into hematopoietic cells and a vari-ety of blood cells (2) . Furthermore, cytokines normally involved in hematopoeisis, such as IL-1, IL-11, and LIF have been shown to induce differentiation of neural precursor cells into dopaminergic neurons (14) .
A number of questions are raised by the present findings that should be addressed not with the aim to answer them now, but rather with the aim to guide ongoing and future research on these issues. Although BMSC express nestin, a commonly used marker of neural precursors, other cells may also transiently express these intermediate filaments. Nestin is found in myogenic cells, in newly formed endothelial cells of extra-and intraembryonic blood vessels, epithelial cells of the developing lens, and hepatic stellate cells (16, 19) . This, of course, raises the issue as to the embryonic origin of nestin-expressing cells outside of the nervous system, but more to the point, nestin is not an exclusive marker of neural precursors. Even the expression by BMSC of a more mature neuronal protein, neuron-specific nuclear protein, is insufficient proof that BMSC become neurons. The expression of one or even two neuronal proteins does not prove that the cell bearing these "neuronal markers" is capable of all the complex functions of a neuron. It will be important to determine whether longer incubation times result in more mature neuron-like cells and whether these cells possess functional and electrophysiological characteristics of neurons. Additional fundamental questions remain to be answered. Identification and characterization of the stem cell or subfraction of BMSC that gives rise to the neural precursor is not yet known, although it is unlikely that hematopoietic stem cells are the source of the neural precursors. The BMSC we utilized were depleted of hematopoietic stem cells and yet gave rise to cells with several neural markers. Given the very small proportion of BMSC that were induced to express neuronal or glial markers, improved procedures need to be developed to enrich the neural precursor population. The present findings, in the context of the rapidly expanding field of stem cell biology, point to bone marrow as an invaluable resource. Understanding the molecular mechanisms responsible for neuronal differentiation of these cells will ultimately yield a readily available source of neural cells for cellular therapies ranging from gene therapeutics to neural reconstruction in neurodegenerative diseases, stroke, and trauma.
